[Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma].
During 1992 and 1993, twenty-eight women with uterine leiomyomata received GnRH-agonist (leuprolide acetate) for 3 months before hysterectomy or myomectomy. The decrease in uterine volume and secondary anemia with its collateral effects were assessed, then surgical and post-surgical advantages were assessed too. The real advantages of this treatment are studied and distinguished from theoretic advantages.
Mignemi
G
G
I Clinica Ostetrica e Ginecologica, Università degli Studi di Catania.
Garozzo
A
A
Livatino
A
A
Di Leo
L
L
D000328:Adult; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000601:surgery*; D016729:Leuprolide / Q000008:administration & dosage*; D011292:Premedication; D014594:Uterine Neoplasms / Q000601:surgery*
D016729:Leuprolide
Impiego clinico di un analogo GnRH in preparazione depot (leuprolide acetato) nelle pazienti affette da fibromiomi uterini con indicazione chirurgica.